Monday, 25 February 2019

Roche bets $4.3 billion on Spark in gene therapy move

Roche Holding AG is to buy U.S.-based Spark Therapeutics in a $4.3 billion deal that will give the Swiss drugmaker a foothold in gene therapy.


Posted by at

No comments:

Post a Comment

Subscribe to: Post Comments (Atom)